Recent Posts
- New Expert Roundtable Publication from National Rosacea Society Emphasizes Importance of Treating Erythema of Rosacea
- EPI Health and MC2 Therapeutics announces U.S. Launch of Wynzora® Cream for Plaque Psoriasis (calcipotriene and betamethasone dipropionate w/w 0.005%/0.064%)
- Highly Significant Head to Head Data for Wynzora® Cream (calcipotriene and betamethasone dipropionate w/w 0.005%/0.064%) for the Treatment of Plaque Psoriasis Accepted to Maui Derm Summer Meeting
- EPI Health Expands Solid Payor Coverage on Rhofade
- EPI Health Announces Rhofade® (oxymetazoline hydrochloride) cream, 1% is now covered on the Express Scripts National Preferred Formulary
Recent Comments